Endpoints News

Regenxbio set to face FDA with pivotal Duchenne data		Read in browser

Thank you for reading, dupa dupackia!

basic

UPGRADE

M T W Thu F

14 May, 2026

Where regulators and industry align on what's next.

sponsored by DIA

presented by

Moving beyond science to access: Solving the access imperative

news

Biogen's anti-tau Alzheimer's drug misses Phase 2 goal, but claims signs of efficacy

Regenxbio's Duchenne study succeeded. Will it be enough to convince the FDA?

BeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta

May 20

11:00 am ET

Application of Simple Western to analysis of antibody target affinity and specificity

sponsored by Bio-Techne

LGBTQ+ diversity drives innovation in biopharma — but transgender and non-binary professionals face rising challenges. Endpoints is going live with our fourth annual special report celebrating the honorees giving voice and visibility while forging ahead across life sciences. Join us.

ENDPOINTS PHARMA

Takeda to target 4,500 jobs as incoming CEO continues restructuring

After an apparent cure, a gene editing company struggles to repeat the magic

Valneva to cut up to 15% of jobs as reduced travel hits vaccine demand

in case you missed it

Post-Hoc: What brought down the FDA commissioner

Behind Galapagos’ transformation into Lakefront Biotherapeutics

Tessera says infusion edits 85% of blood cells, pointing to off-the-shelf sickle cell fix

News Briefing

Abeona pivots to T cells; AstraZeneca's rare disease drug passes Phase 3

Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options

Merck KGaA's clients are stockpiling due to Iran war, supporting guidance boost

Hantavirus scientists were close to vaccine but ran out of money

We’re keeping a close eye on this year’s ASCO, with Lei Lei Wu and Max Gelm an reporting from Chicago at the end of the month. Also, Elizabeth Cairns will be covering the ADA meeting in early June. If you have stories to share, do reach out!

Reynald Castaneda

Deputy Editor, Endpoints News

2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com